Milpharm Ltd Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Location

Ruislip Middlesex UK

Primary Industry

Pharmaceuticals

About

Based in the UK, Milpharm Ltd operates as a manufacturer of pharmaceutical products.

Current Investors

Aurobindo Pharma Ltd.

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Verticals

Manufacturing

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin

31 Mar 2010

9,611,323

311,626

3.2%

680,969

7.1%

328,163

3.4%

31 Mar 2011

11,614,131

20.8%

854,634

7.4%

1,220,303

10.5%

760,333

6.5%

31 Mar 2012

10,478,736

(9.8%)

433,265

4.1%

800,076

7.6%

284,279

2.7%

31 Mar 2013

13,229,234

26.2%

802,447

6.1%

2,053,099

15.5%

594,686

4.5%

31 Mar 2014

18,522,930

40%

1,777,286

9.6%

2,377,626

12.8%

1,330,261

7.2%

31 Mar 2015

21,650,559

16.9%

118,767

0.5%

634,488

2.9%

95,403

0.4%

31 Mar 2016

24,144,911

11.5%

1,650,443

6.8%

2,384,939

9.9%

1,251,584

5.2%

31 Mar 2017

30,537,709

26.5%

1,334,539

4.4%

2,047,403

6.7%

997,379

3.3%

31 Mar 2018

59,562,624

95%

2,913,941

4.9%

3,686,343

6.2%

2,300,733

3.9%

31 Mar 2019

59,618,527

0.1%

3,155,182

5.3%

3,828,990

6.4%

2,536,959

4.3%

31 Mar 2020

64,809,436

8.7%

4,541,994

5,200,385

3,664,065

5.7%

31 Mar 2021

31 Mar 2022

31 Mar 2023

Unlock the recent years of financials and more for Milpharm Ltd.

Request a demo to see more.

Deals

Deals Type
Add-on

Deal Status	Target (s)	Deal Date	Investor(s)	Seller(s)	Deal size (Mn)	Enterprise value (Mn)	Post-money valuation (Mn)	EBITDA multiple (x)	Revenue multiple (x)	Lead partner (s)
Completed	Milpharm Ltd	09 Feb 2006

Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.